InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Tyson Timothy. Director active across 2 companies, notably Tyme Technologies, INC.. Cumulatively, 6 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Activity tracked since 16 September 2022. The latest transaction was filed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
TYSON TIMOTHY is a director at Syros Pharmaceuticals, Inc. and Tyme Technologies, INC. He has 6 filings in total, and in the sampled recent filings the period runs from 2022-09-16 to 2024-06-07, with transactions described as Attribution.